SKVI (Skinvisible) Cyclically Adjusted PB Ratio: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SKVI Skinvisible Inc SKVI
14 GF Score
Price $0.18
GF Value $0.22
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Skinvisible Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Skinvisible  (OTCPK:SKVI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Skinvisible Cyclically Adjusted PB Ratio Related Terms


Skinvisible Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Skinvisible's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skinvisible Cyclically Adjusted PB Ratio Chart

Skinvisible Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Skinvisible Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SKVI vs SNBH, XAGE, BYAH: Cyclically Adjusted PB Ratio Comparison

For the Household & Personal Products subindustry, Skinvisible's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skinvisible Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Skinvisible's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Skinvisible's Cyclically Adjusted PB Ratio falls into.


SKVI
14GF Score
Skinvisible Inc SKVI
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skinvisible Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Skinvisible's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Skinvisible's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.949/330.2130*330.2130
=-1.949

Current CPI (Mar. 2026) = 330.2130.

Skinvisible Quarterly Data

Book Value per Share CPI Adj_Book
201606 -2.783 241.018 -3.813
201609 -2.896 241.428 -3.961
201612 -2.466 241.432 -3.373
201703 -2.647 243.801 -3.585
201706 -2.551 244.955 -3.439
201709 -2.554 246.819 -3.417
201712 -2.470 246.524 -3.309
201803 -2.424 249.554 -3.207
201806 -2.496 251.989 -3.271
201809 -1.752 252.439 -2.292
201812 -1.629 251.233 -2.141
201903 -1.748 254.202 -2.271
201906 -0.770 256.143 -0.993
201909 -0.891 256.759 -1.146
201912 -0.672 256.974 -0.864
202003 -0.769 258.115 -0.984
202006 -0.839 257.797 -1.075
202009 -0.916 260.280 -1.162
202012 -0.981 260.474 -1.244
202103 -1.077 264.877 -1.343
202106 -1.124 271.696 -1.366
202109 -1.169 274.310 -1.407
202112 -1.193 278.802 -1.413
202203 -1.240 287.504 -1.424
202206 -1.282 296.311 -1.429
202209 -1.374 296.808 -1.529
202212 -1.463 296.797 -1.628
202303 -1.775 301.836 -1.942
202306 -1.857 305.109 -2.010
202309 -1.920 307.789 -2.060
202312 -1.987 306.746 -2.139
202403 -2.051 312.332 -2.168
202406 -1.960 314.175 -2.060
202409 -2.018 315.301 -2.113
202412 -1.735 315.605 -1.815
202503 -1.754 319.799 -1.811
202506 -1.805 322.561 -1.848
202509 -1.851 324.800 -1.882
202512 -1.899 324.054 -1.935
202603 -1.949 330.213 -1.949

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Skinvisible (SKVI) Overvalued in 2026?

Based on GuruFocus' analysis, Skinvisible stock appears to be undervalued. The current stock price of $0.18 is trading 18.2% below its estimated GF Value™ of $0.22. GuruFocus considers Skinvisible to be Modestly Undervalued.

Key valuation signals for SKVI:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $0.22 vs. price of $0.18 (18.2% below fair value)
  • GF Score™: 14/100 with 6 warning signs

No single metric tells the full story. See the SKVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Skinvisible Business Description

Address 6320 South Sandhill Road, Unit 9, Las Vegas, NV, USA, 89120
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare, and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
14GF Score

Get the complete analysis for SKVI

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price
$0.22
GF Value